Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents. [electronic resource]
Producer: 20120614Description: 59-69 p. digitalISSN:- 1097-0215
- Antineoplastic Agents, Alkylating -- pharmacology
- Apoptosis
- C-Reactive Protein -- genetics
- CCAAT-Enhancer-Binding Protein-alpha -- genetics
- CCAAT-Enhancer-Binding Protein-beta -- genetics
- Cell Line, Tumor
- DNA Methylation
- DNA Modification Methylases -- deficiency
- DNA Repair
- DNA Repair Enzymes -- deficiency
- Dacarbazine -- analogs & derivatives
- Dioxoles -- pharmacology
- Drug Resistance, Neoplasm
- Fibronectins -- genetics
- Humans
- Liposarcoma, Myxoid -- drug therapy
- Oncogene Proteins, Fusion -- genetics
- Promoter Regions, Genetic
- RNA-Binding Protein FUS -- genetics
- Serum Amyloid P-Component -- genetics
- Signal Transduction
- Temozolomide
- Tetrahydroisoquinolines -- pharmacology
- Trabectedin
- Transcription Factor CHOP -- genetics
- Tumor Suppressor Proteins -- deficiency
- Ultraviolet Rays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.